|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,405 IDR | -1.75% |
|
+0.36% | -12.73% |
| Apr. 01 | PT Kalbe Farma Tbk. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Feb. 20 | Nomura Adjusts Kalbe Farma’s Price Target to IDR1,850 From IDR2,500, Keeps at Buy | MT |
PT Kalbe Farma Tbk. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was IDR 28,933,502.65 million compared to IDR 26,261,194.51 million a year ago.
Net income was IDR 3,382,209.77 million compared to IDR 3,183,621.31 million a year ago. Basic earnings per share from continuing operations was IDR 72.71 compared to IDR 67.92 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -12.73% | 4.01B | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
PT KALBE FARMA TBK. 
